Results 101 to 110 of about 179 (138)

Secreción inadecuada de vasopresina y valproato

Endocrinologia Y Nutricion: Organo De La Sociedad Espanola De Endocrinologia Y Nutricion, 2009
Silvia Franco Hidalgo   +2 more
exaly   +2 more sources

Trastorno cognitivo inducido por valproato

Medicina Clínica, 2000
Xavier Montalbán
exaly   +2 more sources

Meropenem disminuye los niveles plasmáticos de valproato

Medicina Clínica, 2011
María Isabel Fernández García   +3 more
exaly   +2 more sources

Il valproato tra terapia e tossicità tubulare: viaggio all'interno della sindrome di Fanconi

Medico E Bambino Pagine Elettroniche
Fanconi Syndrome (FS) is a proximal renal tubular dysfunction characterised by the urinary loss of normally reabsorbed substances. Although rare, it may occur as an iatrogenic complication of valproic acid (VPA) therapy in children. The paper reports the case of a 3-year-old boy (Trisomy 21, PEG-fed) treated with VPA for six months.
Andrea Pasini, Roberto Pillon
exaly   +2 more sources

Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands

Journal of Inorganic Biochemistry, 2014
We report new anticancer prodrugs, platinum(IV) derivatives of oxaliplatin conjugated with valproic acid (VPA), a well-known drug having histone deacetylase inhibitory activity. Like most platinum(IV) derivatives, the cytotoxicity of the conjugates was lower in cell culture than that of oxaliplatin, but greater than those of its Pt(IV) derivative ...
Vojtech, Novohradsky   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy